Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Horak

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Cold Spring Harbor Molecular Case Studies|December 1, 2016
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with <i>PDL1</i> amplificationStefan Gröschel, Martin Bommer, Barbara Hutter, et al.
Molecular Cancer Therapeutics|July 17, 2019
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors - TORC1/2 Inhibition as Salvage StrategyThomas Mühlenberg, Julia Ketzer, Michael C Heinrich, et al.
Cold Spring Harbor Molecular Case Studies|March 6, 2019
Response to olaparib in a <i>PALB2</i> germline mutated prostate cancer and genetic events associated with resistancePeter Horak, Joachim Weischenfeldt, Gunhild von Amsberg, et al.
Leukemia|November 17, 2021
Publisher Correction: Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemiaPeter Horak, Sebastian Uhrig, Maximilian Witzel, et al.
Oncogene|September 28, 2019
Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domainsFlorian Weinberg, Ricarda Griffin, Martina Fröhlich, et al.
Leukemia|March 5, 2020
Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemiaPeter Horak, Sebastian Uhrig, Maximilian Witzel, et al.
Nature Communications|January 19, 2026
The Knowledge Connector decision support system for multiomics-based precision oncologyDaniel Hübschmann, Simon Kreutzfeldt, Benjamin Roth, et al.
Genes, Chromosomes & Cancer|July 31, 2021
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicinePeter Horak, Jonas Leichsenring, Hannah Goldschmid, et al.
Cell Reports. Medicine|September 21, 2023
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivityAlexander A Wurm, Silke Brilloff, Sofia Kolovich, et al.
Nature Communications|June 12, 2025
A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancerErika Zuljan, Benjamin von der Emde, Iris Piwonski, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Cold Spring Harbor Molecular Case Studies|December 1, 2016
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with <i>PDL1</i> amplificationStefan Gröschel, Martin Bommer, Barbara Hutter, et al.
Molecular Cancer Therapeutics|July 17, 2019
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors - TORC1/2 Inhibition as Salvage StrategyThomas Mühlenberg, Julia Ketzer, Michael C Heinrich, et al.
Cold Spring Harbor Molecular Case Studies|March 6, 2019
Response to olaparib in a <i>PALB2</i> germline mutated prostate cancer and genetic events associated with resistancePeter Horak, Joachim Weischenfeldt, Gunhild von Amsberg, et al.
Leukemia|November 17, 2021
Publisher Correction: Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemiaPeter Horak, Sebastian Uhrig, Maximilian Witzel, et al.
Oncogene|September 28, 2019
Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domainsFlorian Weinberg, Ricarda Griffin, Martina Fröhlich, et al.
Leukemia|March 5, 2020
Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemiaPeter Horak, Sebastian Uhrig, Maximilian Witzel, et al.
Nature Communications|January 19, 2026
The Knowledge Connector decision support system for multiomics-based precision oncologyDaniel Hübschmann, Simon Kreutzfeldt, Benjamin Roth, et al.
Genes, Chromosomes & Cancer|July 31, 2021
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicinePeter Horak, Jonas Leichsenring, Hannah Goldschmid, et al.
Cell Reports. Medicine|September 21, 2023
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivityAlexander A Wurm, Silke Brilloff, Sofia Kolovich, et al.
Nature Communications|June 12, 2025
A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancerErika Zuljan, Benjamin von der Emde, Iris Piwonski, et al.
Pageof 14